MedTrace Logo

Efficacy of Platelet-Rich Plasma Injection in Dry Eye Syndrome

NCT06831253 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-03-19

No results posted yet for this study

Summary

The investigatror wants to show the efficacy of Platelet-Rich Plasma injection in lacrimal gland to restore the lacrimal secretion in patients presenting aqueous deficiency reponsible for severe dry eye syndrome.

Conditions

  • Severe Dry Eye Syndromes
  • Dry Eye Syndromes

Interventions

OTHER

injections of Platelet-Rich Plasma in lacrimal gland

injections of Platelet-Rich Plasma in lacrimal gland

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nice

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-17
Primary Completion
2026-03-01
Completion
2026-07-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06831253 on ClinicalTrials.gov